A method of pharmaceutically managing snoring is provided by the instillation intranasally of a solution containing 1-20% methylsulfonylmethane by weight dissolved in water so as to saturate the nasal mucous membranes. Preferably, the solution has between 10%-16% by weight methysulfonylmethane. The solution...http://www.google.fr/patents/US5569679?utm_source=gb-gplus-shareBrevet US5569679 - Pharmacologic management of snoring
